Jasper Therapeutics (NASDAQ:JSPR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Jasper Therapeutics Stock (NASDAQ: JSPR) stock price, news, charts, stock research, profile.

Open	$21.57
Close	$21.18
Volume / Avg.	244.72K / 256.94K
Day Range	$20.92 - $22.05
52 Wk Range	4.00 - 31.01
Market Cap	$319.93M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	12.14%
Days to Cover	5.04

Recent News

Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday?

Jasper Therapeutics' SPOTLIGHT study reports 93% clinical response in cold urticaria and symptomatic dermographism. The 120mg dose showed 83% complete response and no severe adverse events. Full data expected by mid-2025.

Vandana Singh

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$21.57
Close	$21.18
Volume / Avg.	244.72K / 256.94K
Day Range	$20.92 - $22.05
52 Wk Range	4.00 - 31.01
Market Cap	$319.93M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	12.14%
Days to Cover	5.04

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Jasper Therapeutics (JSPR) stock?

You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.

View our list of the best stock brokerages

Who are Jasper Therapeutics (JSPR) competitors?

Other companies in Jasper Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Voyager Therapeutics (NASDAQ:VYGR), Inozyme Pharma (NASDAQ:INZY), Sage Therapeutics (NASDAQ:SAGE) and Fate Therapeutics (NASDAQ:FATE).

What is the forecast, or price target, for Jasper Therapeutics (JSPR) stock?

Jasper Therapeutics has a consensus price target of $50.17.

What is the current price for Jasper Therapeutics (JSPR)?

The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $21.18 last updated October 31, 2024 at 4:00 PM EDT.

Does Jasper Therapeutics (JSPR) pay a dividend?

There are no upcoming dividends for Jasper Therapeutics.

When is Jasper Therapeutics (NASDAQ:JSPR) reporting earnings?

Jasper Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.

Is Jasper Therapeutics (JSPR) going to split?

There is no upcoming split for Jasper Therapeutics.

What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Jasper Therapeutics

Jasper Therapeutics (JSPR) Forecast